Over 90% of experimental autism drugs fail in human trials, largely because standard lab animals—mice and monkeys—cannot mimic the complex social behaviors that autism affects. A new review argues that dogs, who co-evolved with humans for 30,000 years, could bridge this gap.
What the Research Found
Dr. Siqi Yuan and colleagues published a Perspective in Genomic Psychiatry (June 2026) synthesizing a decade of studies on Shank3 mutant laboratory Beagles. Shank3 is a gene strongly linked to autism in humans. The mutant dogs show a suite of autism-like traits: they withdraw from social contact, avoid eye gaze from humans, and have altered sensitivity to sound, touch, and pain. The review also highlights early drug tests: intranasal oxytocin restored maternal bonding and eye-gaze duration, while low-dose psychedelics re-established dog-handler physiological synchrony. Targeted compounds that nudge neural activity toward excitation improved tactile sensitivity and social interaction.
Why It Matters for Your Brain
Better animal models mean better drug screening, which could eventually lead to medications that actually work for core autism symptoms like social withdrawal and sensory issues. For anyone interested in cognition, this work underscores how social bonding and sensory processing rely on shared biological pathways across species. It also highlights the potential of repurposing compounds like oxytocin or psychedelics to enhance social cognition.
What You Can Do
While we wait for new drugs, you can boost your own social and sensory skills through brain training exercises. Try face-reading practice, sensory discrimination games, or eye-contact exercises. Many of these are available on brain training platforms like iqgenio.
Source: Neuroscience News
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.
